Sibylla Biotech S.p.A.
Services
Sibylla plays a role in the B2B drug discovery market, targeting Pharma industries’ need of out-sourcing discovery and preclinical studies.
Most popular related searches
cell-based assay
preclinical trial
pharmaceutical industry
drug discovery
pharmaceutical biotechnology
drug target
pharmaceutical market
As a service-based activity, we may work in collaboration with Pharmaceutical and Biotech companies.
We can apply the PPI-FIT protocol to targets of their interest, delivering the identification of new druggable pockets identified on the folding intermediate state and eventually virtual hits or identified hits on cell-based assays.